Feature | July 13, 2011

Varian’s Radiotherapy Delivery System Wins International Award for Product Design

July 13, 2011 – Varian's TrueBeam radiotherapy delivery system, a comprehensive re-design of linear accelerator technology, has won a top international design award. Launched last year, the sleek and fully integrated TrueBeam system has been selected for a prestigious Red Dot award for product design.

The Red Dot organization, based in Essen, Germany, awards prizes annually for product design, design agencies and design concepts. This year, designers and companies from 60 countries entered almost 4,500 products in the Red Dot award for product design and the winners were announced at an awards ceremony in Essen. More information about the awards and a list of winners can be found at www.red-dot.org.

"As always, our jury cast a very careful eye over the products submitted," said Professor Peter Zec, M.D., the initiator of the Red Dot design award. "Design quality has asserted itself clearly in the judging process, with genuine and new creative solutions also being rewarded. Both of these criteria are not just yardsticks for good design, but also for the potential for success on the market."

TrueBeam was developed to treat tumors in a fast and precise manner, including tumors that move during treatment as the patient breathes in and out. Designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, TrueBeam features a multitude of technical innovations that dynamically synchronize imaging, patient positioning, motion management and treatment delivery. The system was engineered by Varian's development team, with industrial design executed in collaboration with the BMW Group DesignWorksUSA.

TrueBeam can quickly and precisely deliver a broad range of radiotherapy treatments, from stereotactic radiosurgery and stereotactic body radiotherapy to image-guided intensity modulated and volumetric radiotherapy treatments. With its High Intensity Mode, TrueBeam can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of technology. Since its launch in April 2010, Varian has taken orders for over 220 TrueBeam systems, while more than 65 installations are complete or in progress in all parts of the world.

For more information: www.varian.com

Related Content

Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
MedLever Showcases Radiation Oncology Applications at ASTRO 2017
News | Radiation Therapy | October 05, 2017
MedLever demonstrated its flagship platform and applications that simplify clinical workflow, enable interoperability,...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
Overlay Init